Key Metrics
CiteScore 

5.3
Impact Factor 

< 5
SJR 

Q3Endocrinology, Diabetes and Metabolism

SNIP 

1.33
Recommended pre-submission checks
Powered by 

Topics Covered on Therapeutic Advances in Endocrinology and Metabolism
Therapeutic Advances in Endocrinology and Metabolism Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Endocrinology and Metabolism ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Therapeutic Advances in Endocrinology and Metabolism
Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study
- 11 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism
NT-proBNP and its association with autonomous aldosterone production in primary aldosteronism
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Exploring the link between atherosclerosis indicators and QT interval in type 2 diabetes: a retrospective cross-sectional analysis
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Multisystem pathology in chronic variable stress: gut\u2013liver\u2013brain axis disruption and the therapeutic promise of magnesium-L-theanine
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association and prognostic value of adiposity distribution indices for all-cause mortality in cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide study
- 19 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association is not yet an indication: concerns about monitoring claims and residual confounding in outpatient metformin-associated lactate elevation
- 18 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association of prediabetes phenotypes with metabolic dysfunction-associated fatty liver disease and liver fibrosis: a population-based study
- 11 Jun 2026
- Therapeutic Advances in Endocrinology and Metabolism
NT-proBNP and its association with autonomous aldosterone production in primary aldosteronism
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Exploring the link between atherosclerosis indicators and QT interval in type 2 diabetes: a retrospective cross-sectional analysis
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Multisystem pathology in chronic variable stress: gut\u2013liver\u2013brain axis disruption and the therapeutic promise of magnesium-L-theanine
- 21 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association and prognostic value of adiposity distribution indices for all-cause mortality in cardiovascular-kidney-metabolic syndrome stages 0\u20133: a nationwide study
- 19 May 2026
- Therapeutic Advances in Endocrinology and Metabolism
Association is not yet an indication: concerns about monitoring claims and residual confounding in outpatient metformin-associated lactate elevation
- 18 May 2026
- Therapeutic Advances in Endocrinology and Metabolism